Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Kenvue: Dude, Where's My Dividend Growth?
11:21am, Sunday, 26'th Nov 2023
Dividend stocks became unattractive due to weak equities and high Treasury rates, but some are starting to look more attractive again. Kenvue, a spin-off from Johnson & Johnson, lacks growth potential
Top 5 Stocks The Smart Money Is Buying
09:38am, Tuesday, 21'st Nov 2023
Hedge funds are managed by professional fund managers and consist of pooled investment funds from various investors. Hedge funds must file a 13-F with the SEC, which shows their buys and sells for the
7 Safe Stocks to Buy if You Think Q3's Gangbuster Growth Won't Last
09:26am, Thursday, 09'th Nov 2023
At first glance, the proposal to dive into safe stocks to buy might appear overly conservative. As NPR recently pointed out, the U.S. GDP grew 4.9% in the third quarter, catalyzed by stronger-than-exp
U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO
12:21am, Saturday, 04'th Nov 2023
Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&P 500 was
The 3 Best Forever Stocks to Buy in November
08:42am, Friday, 03'rd Nov 2023
Anytime you bring up the concept of “forever stocks,” you're running the risk of incurring a serious tail risk. Obviously, forever is a long time – long enough for something to go wrong.
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?
07:44am, Wednesday, 01'st Nov 2023
Kenvue stock pays a fairly high dividend that yields 4.4%. The company is expecting modest revenue growth of around 6% this year.
Kenvue Inc. (KVUE) Q3 2023 Earnings Call Transcript
01:48am, Saturday, 28'th Oct 2023
Kenvue Inc (NYSE:KVUE ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Tina Romani - Head of Investor Relations Thibaut Mongon - Chief Executive Officer and Director
Sanofi to create its own Haleon, Kenvue as its stock price tumbles
03:05am, Friday, 27'th Oct 2023
Sanofi (FRA: SNW), the giant healthcare company, is considering spinning off its consumer health business. In a statement, the management said it was hoping to create a separate company listed in Fran
Kenvue CEO Thibaut Mongon: We feel very good about the strength of our business model
11:40am, Thursday, 26'th Oct 2023
Kenvue CEO Thibaut Mongon joins ‘Squawk on the Street' to discuss the company's latest quarter, their new products in the market, and more.
Kenvue shares lower amid slow start to cold and flu season
07:36am, Thursday, 26'th Oct 2023
Kenvue Inc's shares fell 1.7% in pre-market trading after the company posted in-line third-quarter earnings but tightened its full-year guidance after a slow start to the flu and cold season. The comp
Kenvue's stock slides premarket as company reports slow start to flu and cold season
06:53am, Thursday, 26'th Oct 2023
Kenvue Inc.'s stock KVUE, -1.25% fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after a slow start to the flu and c
Kenvue reports higher Q3 revenue on self-care products strength
06:37am, Thursday, 26'th Oct 2023
Kenvue on Thursday reported higher third-quarter revenue, owing to strong demand for its self-care and skincare products such as Tylenol and Neutrogena.
Kenvue is one of few IPOs trading cheap relative to long-term value: Lido Advisors' Gina Sanchez
02:28pm, Friday, 20'th Oct 2023
Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss IPOs performing below their debut prices, defensive IPO names to buy, and what names consumers will be willing to p
Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond
02:17am, Thursday, 19'th Oct 2023
Kenvue Inc., a subsidiary of Johnson & Johnson, is a major player in the consumer health industry with a diverse range of products. The company successfully completed its IPO, generating net proceeds
An IPO Pro Buys More Palantir, Rivian, and Kenvue. It Sold Li Auto.
08:00am, Sunday, 15'th Oct 2023
Renaissance Capital LLC's passive IPO-focused ETFs loaded up on Palantir, Rivian, and Kenvue stock, and exited an investment in Li Auto in the third quarter.
